Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Amass

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Experimental and Clinical Psychopharmacology|May 5, 2004
A tale of two cities: financing two voucher programs for substance abusers through community donationsLeslie Amass, Jonathan Kamien
Journal of Addiction Medicine|July 20, 2011
Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice SettingJames W Finch, Jonathan B Kamien, Leslie Amass
Drug and Alcohol Dependence|May 10, 2003
Buprenorphine: how to use it rightRolley E Johnson, Eric C Strain, Leslie Amass
Addictive Behaviors|August 1, 2006
Characteristics and HIV risk behaviors of homeless, substance-using men who have sex with menCathy J Reback, Jonathan B Kamien, Leslie Amass
Cardiology and Therapy|June 20, 2021
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOSLuca Gentile, Ivailo Tournev, Leslie Amass, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2017
Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trialDenis Keohane, Jeffrey Schwartz, Balarama Gundapaneni, et al.
Journal of Substance Abuse Treatment|June 29, 2007
A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatmentSteven A Branstetter, Emily H Bower, Jonathan Kamien, et al.
Journal of Substance Abuse Treatment|May 8, 2007
Using buprenorphine short-term taper to facilitate early treatment engagementGregory S Brigham, Leslie Amass, Theresa Winhusen, et al.
Journal of Substance Abuse Treatment|February 20, 2007
Using buprenorphine to facilitate entry into residential therapeutic community rehabilitationEric D Collins, Terry Horton, Katherine Reinke, et al.
Journal of the Peripheral Nervous System : JPNS|April 12, 2021
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Márcia Waddington-Cruz, Yukio Ando, Leslie Amass, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Experimental and Clinical Psychopharmacology|May 5, 2004
A tale of two cities: financing two voucher programs for substance abusers through community donationsLeslie Amass, Jonathan Kamien
Journal of Addiction Medicine|July 20, 2011
Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice SettingJames W Finch, Jonathan B Kamien, Leslie Amass
Drug and Alcohol Dependence|May 10, 2003
Buprenorphine: how to use it rightRolley E Johnson, Eric C Strain, Leslie Amass
Addictive Behaviors|August 1, 2006
Characteristics and HIV risk behaviors of homeless, substance-using men who have sex with menCathy J Reback, Jonathan B Kamien, Leslie Amass
Cardiology and Therapy|June 20, 2021
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOSLuca Gentile, Ivailo Tournev, Leslie Amass, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2017
Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trialDenis Keohane, Jeffrey Schwartz, Balarama Gundapaneni, et al.
Journal of Substance Abuse Treatment|June 29, 2007
A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatmentSteven A Branstetter, Emily H Bower, Jonathan Kamien, et al.
Journal of Substance Abuse Treatment|May 8, 2007
Using buprenorphine short-term taper to facilitate early treatment engagementGregory S Brigham, Leslie Amass, Theresa Winhusen, et al.
Journal of Substance Abuse Treatment|February 20, 2007
Using buprenorphine to facilitate entry into residential therapeutic community rehabilitationEric D Collins, Terry Horton, Katherine Reinke, et al.
Journal of the Peripheral Nervous System : JPNS|April 12, 2021
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Márcia Waddington-Cruz, Yukio Ando, Leslie Amass, et al.
Pageof 5